MJRIC
AGN

Mogy Joel R Investment Counsel’s Allergan Inc AGN Stock Holding History

Mogy Joel R Investment Counsel’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-30,600
Closed -$6.5M – 147
2014
Q4 		$6.5M Sell
30,600
-4,450
-13% -$885K 1.23% 28
2014
Q3 		$6.25M Sell
35,050
-300
-0.8% -$49.8K 1.26% 27
2014
Q2 		$5.98M Sell
35,350
-1,000
-3% -$156K 1.2% 27
2014
Q1 		$4.51M Sell
36,350
-50
-0.1% -$6.09K 0.94% 37
2013
Q4 		$4.04M Buy
36,400
+550
+2% +$52.5K 0.86% 41
2013
Q3 		$3.24M Buy
35,850
+6,950
+24% +$624K 0.74% 43
2013
Q2 		$2.44M Buy
+28,900
New +$3M 0.59% 48

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Mogy Joel R Investment Counsel's AGN Position: Q1 2015 in Review

Mogy Joel R Investment Counsel sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 30,600 shares — an estimated $6.5M sold.

Mogy Joel R Investment Counsel first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $6.5M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Mogy Joel R Investment Counsel reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Mogy Joel R Investment Counsel sold 30,600 Allergan Inc shares in Q1 2015, an estimated $6.5M.
  • Mogy Joel R Investment Counsel first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Mogy Joel R Investment Counsel's Allergan Inc position peaked at $6.5M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Mogy Joel R Investment Counsel's 13F filing for Q1 2015, filed 15 May 2015.